Hepatocellular carcinoma recurrence condition prediction method and system based on combination of MRI image and clinical features
By combining MRI images and clinical features, the problem of poor prediction results caused by relying on CT images and case indicator data in the prior art is solved, and higher prediction accuracy and personalized medical support are achieved.
Patent Information
- Application Number
- CN202411729666.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-11-29
- Publication Date
- 2025-03-21
AI Technical Summary
When predicting the risk of early postoperative recurrence in patients with hepatocellular carcinoma, the prior art relies on a large number of CT images and case index data. The data quality and quantity directly affect the model performance, resulting in poor prediction results.
A multimodal deep learning model combining MRI images and clinical features is used to denoise, normalize and size adjustment of MRI images, and fill missing values and encode clinical feature data, extract image features and clinical features, and input deep learning models for training after fusion to generate a prediction model for hepatocellular carcinoma recurrence.
It improves the accuracy and reliability of prediction of hepatocellular carcinoma recurrence, provides support for personalized medical care, and has significant clinical application value and research significance.